Syntr Health Technologies Announces FDA Clearance of the SyntrFuge System for use in Specialty Surgeries Requiring Transfer and Implantation of Patient’s Own Fat Tissue

IRVINE, Calif.: IRVINE, Calif., Aug. 12, 2021 /PRNewswire/ -- Syntr Health Technologies, Inc., a medical device company specializing in the processing of autologous adipose tissue, also known as fat tissue, today announced clearance from the US Food & Drug Administration (FDA) for the company's patented SyntrFuge Systemâ„¢ for use in...

Click to view original post